Similar articles

• Clinical results with alpha-blockers in patients with symptomatic benign prostatic hyperplasia.

  Mensink HJ. Mensink HJ. Prog Clin Biol Res. 1994;386:285-9. Prog Clin Biol Res. 1994. PMID: 7528396 Review. No abstract available.
• Alfuzosin for benign prostatic hypertrophy.

  Jardin A, Bensadoun H, Delauche-Cavallier MC, Attali P. Jardin A, et al. Lancet. 1991 Oct 12;338(8772):947. doi: 10.1016/0140-6736(91)91814-b. Lancet. 1991. PMID: 1717801 No abstract available.
• [Alfuzosin. A new selective alpha 1 receptor antagonist for symptomatic medical treatment of benign prostatic hypertrophy prior to surgery].

  Hansen BJ, Meyhoff HH. Hansen BJ, et al. Ugeskr Laeger. 1992 Feb 3;154(6):361-2. Ugeskr Laeger. 1992. PMID: 1371629 Danish. No abstract available.
• Alfuzosin (uroxatral)--another alpha1-blocker for benign prostatic hyperplasia.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2004 Jan 5;46(1173):1-2. Med Lett Drugs Ther. 2004. PMID: 14691408 No abstract available.
• [Alpha blockers in the treatment of benign hyperplasia of the prostate].

  Gómez Sancha F, Fernández Arjona M, Peinado Ibarra F, Fernández Borrell A, Mínguez Martínez R, Pereira Sanz I. Gómez Sancha F, et al. Rev Clin Esp. 1997 May;197(5):358-62. Rev Clin Esp. 1997. PMID: 9280971 Review. Spanish. No abstract available.